Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Publication year range
1.
Int J Clin Pharm ; 46(3): 602-613, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38570475

ABSTRACT

BACKGROUND: Key performance indicators (KPIs) are quantifiable measures used to monitor the quality of health services. Implementation guidelines for clinical pharmacy services (CPS) do not specify KPIs. AIM: To assess the quality of the studies that have developed KPIs for CPS in inpatient hospital settings. METHOD: A systematic review was conducted by searching in Web of Science, Scopus, and PubMed, supplemented with citation analyses and grey literature searches, to retrieve studies addressing the development of KPIs in CPS for hospital inpatients. Exclusions comprised drug- or disease-specific studies and those not written in English, French, Portuguese, or Spanish. The Appraisal of Indicators through Research and Evaluation (AIRE) instrument assessed methodological quality. Domain scores and an overall score were calculated using an equal-weight principle. KPIs were classified into structure, process, and outcome categories. The protocol is available at https://doi.org/10.17605/OSF.IO/KS2G3 . RESULTS: We included thirteen studies that collectively developed 225 KPIs. Merely five studies scored over 50% on the AIRE instrument, with domains #3 (scientific evidence) and #4 (formulation and usage) displaying low scores. Among the KPIs, 8.4% were classified as structure, 85.8% as process, and 5.8% as outcome indicators. The overall methodological quality did not exhibit a clear association with a major focus on outcomes. None of the studies provided benchmarking reference values. CONCLUSION: The KPIs formulated for evaluating CPS in hospital settings primarily comprised process measures, predominantly suggested by pharmacists, with inadequate evidence support, lacked piloting or validation, and consequently, were devoid of benchmarking reference values.


Subject(s)
Inpatients , Pharmacy Service, Hospital , Quality Indicators, Health Care , Pharmacy Service, Hospital/standards , Humans , Quality Indicators, Health Care/standards
2.
Rev. colomb. cir ; 38(3): 413-421, Mayo 8, 2023. tab, fig
Article in Spanish | LILACS | ID: biblio-1438383

ABSTRACT

Introducción. Las listas de espera para cirugía de alta prevalencia son producto de una limitada oferta ante una elevada demanda de jornadas quirúrgicas. Tienen un impacto sobre las condiciones médicas de los pacientes y la consulta por urgencias. Como respuesta, se han incorporado los espacios quirúrgicos adicionales en horarios no convencionales. Su creciente implementación, aunque controversial, se reconoce cada vez más como una nueva normalidad en cirugía. Hay una limitada documentación de la efectividad de la medida, debido a la complejidad e intereses de los participantes. Métodos. Se analizó desde una posición crítica y reflexiva la perspectiva de los actores involucrados en un programa de cirugía en horario extendido, estableciendo las posibles barreras y los elementos facilitadores de una política enfocada a procedimientos en horario no convencional. Asimismo, se describen posibles oportunidades de investigación en el tema. Discusión. Los programas quirúrgicos en horarios no convencionales implican un análisis de los determinantes de su factibilidad y éxito para establecer la pertinencia de su implementación. La disponibilidad de las salas de cirugía, una estandarización de los procedimientos y una cultura de seguridad institucional implementada por la normativa vigente, favorecen estas acciones operacionales. Los aspectos económicos del prestador y del asegurador inciden en la planeación y ejecución de esta modalidad de trabajo. Conclusión. La realización segura y el éxito de un programa de cirugía en horario no convencional dependen de la posibilidad de alinear los intereses de los actores participantes en el proceso


Introduction. Waiting lists for high-prevalence surgeries are the product of limited supply due to a high demand for surgical days. They have an impact on patients' medical conditions and emergency consultation. In response, additional surgical spaces have been incorporated at unconventional times. Its growing implementation, although controversial, is increasingly recognized as a new normal in surgery. There is limited documentation of the effectiveness of the measure due to the complexity and interests of the participants. Methods. The perspective of the actors involved in an extended hours surgery program was analyzed from a critical and reflective position, establishing the possible barriers, and facilitating elements of a policy focused on procedures during unconventional hours. Possible research opportunities on the topic are also described. Discussion. Surgical programs at unconventional times involve an analysis of the determinants of their feasibility and success to establish the relevance of implementation. The availability of operating rooms, a standardization of procedures and a culture of institutional security implemented by current regulations, favor these operational actions. The economic aspects of the provider and the insurer affect the planning and execution of this type of work. Conclusion. The safe realization and success of a surgical program in unconventional hours depend on the possibility of aligning the interests of the actors involved in the process


Subject(s)
Humans , Outcome and Process Assessment, Health Care , Personnel Staffing and Scheduling , General Surgery , Postoperative Complications , Process Optimization , Patient Safety
3.
Adv Rheumatol ; 63(1): 17, 2023 04 24.
Article in English | MEDLINE | ID: mdl-37095556

ABSTRACT

BACKGROUND: Early rheumatoid arthritis (RA) offers an opportunity for better treatment outcomes. In real-life settings, grasping this opportunity might depend on access to specialized care. We evaluated the effects of early versus late assessment by the rheumatologist on the diagnosis, treatment initiation and long-term outcomes of RA under real-life conditions. METHODS: Adults meeting the ACR/EULAR (2010) or ARA (1987) criteria for RA were included. Structured interviews were conducted. The specialized assessment was deemed "early" when the rheumatologist was the first or second physician consulted after symptoms onset, and "late" when performed afterwards. Delays in RA diagnosis and treatment were inquired. Disease activity (DAS28-CRP) and physical function (HAQ-DI) were evaluated. Student's t, Mann-Whitney U, chi-squared and correlation tests, and multiple linear regression were performed. For sensitivity analysis, a propensity score-matched subsample of early- vs. late-assessed participants was derived based on logistic regression. The study received ethical approval; all participants signed informed consent. RESULTS: We included 1057 participants (89.4% female, 56.5% white); mean (SD) age: 56.9 (11.5) years; disease duration: 173.1 (114.5) months. Median (IQR) delays from symptoms onset to both RA diagnosis and initial treatment coincided: 12 (6-36) months, with no significant delay between diagnosis and treatment. Most participants (64.6%) first sought a general practitioner. Notwithstanding, 80.7% had the diagnosis established only by the rheumatologist. Only a minority (28.7%) attained early RA treatment (≤ 6 months of symptoms). Diagnostic and treatment delays were strongly correlated (rho 0.816; p < 0.001). The chances of missing early treatment more than doubled when the assessment by the rheumatologist was belated (OR 2.77; 95% CI: 1.93, 3.97). After long disease duration, late-assessed participants still presented lower chances of remission/low disease activity (OR 0.74; 95% CI: 0.55, 0.99), while the early-assessed ones showed better DAS28-CRP and HAQ-DI scores (difference in means [95% CI]: -0.25 [-0.46, -0.04] and - 0.196 [-0.306, -0.087] respectively). The results in the propensity-score matched subsample confirmed those observed in the original (whole) sample. CONCLUSIONS: Early diagnosis and treatment initiation in patients with RA was critically dependent on early access to the rheumatologist; late specialized assessment was associated with worse long-term clinical outcomes.


Subject(s)
Antirheumatic Agents , Arthritis, Rheumatoid , Adult , Humans , Female , Middle Aged , Male , Antirheumatic Agents/therapeutic use , Arthritis, Rheumatoid/drug therapy , Treatment Outcome , Remission Induction , Rheumatologists
4.
Argentinian j. respiratory physical therapy ; 5(1): 44-51, 2023. tab, graf
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1573876

ABSTRACT

RESUMEN Introducción: El tratamiento del tumor de fosa posterior implica la resección quirúrgica, sola o en combinación con tratamientos coadyuvantes, como la radioterapia y quimioterapia. Luego de la resección quirúrgica, el 20-30% de los niños presentan síndrome de fosa posterior. En esta serie de casos, describimos el abordaje médico y la recuperación funcional de tres niños con síndrome de fosa posterior en una clínica de rehabilitación de Buenos Aires. Presentación de los casos: Se analizaron tres niños (dos de sexo masculino y uno femenino), de entre 5 y 15 años de edad, con síndrome de fosa posterior dentro de los 30 días postquirúrgicos e internados para neurorrehabilitación entre el 2016 y 2021. Se realizaron evaluaciones, previo y posterior a la rehabilitación, de los hallazgos en los estudios de imágenes, de las manifestaciones neurológicas mediante la escala para la evaluación y calificación de la ataxia (SARA) y de la movilidad funcional mediante la escala de movilidad funcional (FMS). Conclusión: Al alta del centro de rehabilitación, los tres niños evidenciaron mejoría en las manifestaciones neurológicas, la movilidad funcional y los hallazgos en las imágenes. Sugerimos la realización de estudios prospectivos con mayor tamaño mue stral y utilizando escalas validadas.


ABSTRACT Introduction: The treatment of posterior fossa tumors involves surgical resection, either alone or in combination with adjuvant treatments, such as radiotherapy and chemotherapy. After surgical resection, 20-30% of children experience posterior fossa syndrome. In this case series, we describe the medical approach and functional recovery of three children with posterior fossa syndrome in a rehabilitation center in Buenos Aires. Case presentation: Three children (two male and one female), between 5 and 15 years of age, with posterior fossa syndrome within 30 days after surgery, and hospitalized for neurorehabilitation between 2016 and 2021 were analyzed. We evaluated imaging findings, neurological manifestations with the scale for the assessment and rating of ataxia (SARA), and functional mobility with the functional mobility scale (FMS) before and after rehabilitation. Conclusion: Upon discharge from the rehabilitation center, all three children showed improvement in neurological manifestations, functional mobility, and imaging findings. We suggest conducting prospective studies on a larger sample size and with validated scales.

6.
Adv Rheumatol ; 63: 17, 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1447135

ABSTRACT

Abstract Background Early rheumatoid arthritis (RA) offers an opportunity for better treatment outcomes. In real-life settings, grasping this opportunity might depend on access to specialized care. We evaluated the effects of early versus late assessment by the rheumatologist on the diagnosis, treatment initiation and long-term outcomes of RA under real-life conditions. Methods Adults meeting the ACR/EULAR (2010) or ARA (1987) criteria for RA were included. Structured interviews were conducted. The specialized assessment was deemed "early" when the rheumatologist was the first or second physician consulted after symptoms onset, and "late" when performed afterwards. Delays in RA diagnosis and treatment were inquired. Disease activity (DAS28-CRP) and physical function (HAQ-DI) were evaluated. Student's t, Mann-Whitney U, chi-squared and correlation tests, and multiple linear regression were performed. For sensitivity analysis, a propensity score-matched subsample of early- vs. late-assessed participants was derived based on logistic regression. The study received ethical approval; all participants signed informed consent. Results We included 1057 participants (89.4% female, 56.5% white); mean (SD) age: 56.9 (11.5) years; disease duration: 173.1 (114.5) months. Median (IQR) delays from symptoms onset to both RA diagnosis and initial treatment coincided: 12 (6-36) months, with no significant delay between diagnosis and treatment. Most participants (64.6%) first sought a general practitioner. Notwithstanding, 80.7% had the diagnosis established only by the rheumatologist. Only a minority (28.7%) attained early RA treatment (≤ 6 months of symptoms). Diagnostic and treatment delays were strongly correlated (rho 0.816; p < 0.001). The chances of missing early treatment more than doubled when the assessment by the rheumatologist was belated (OR 2.77; 95% CI: 1.93, 3.97). After long disease duration, late-assessed participants still presented lower chances of remission/low disease activity (OR 0.74; 95% CI: 0.55, 0.99), while the early-assessed ones showed better DAS28-CRP and HAQ-DI scores (difference in means [95% CI]: −0.25 [−0.46, −0.04] and − 0.196 [−0.306, −0.087] respectively). The results in the propensity-score matched subsample confirmed those observed in the original (whole) sample. Conclusions Early diagnosis and treatment initiation in patients with RA was critically dependent on early access to the rheumatologist; late specialized assessment was associated with worse long-term clinical outcomes.

SELECTION OF CITATIONS
SEARCH DETAIL